In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

NHS (Pharmaceutical Services) (Wales) Regulations 2020

The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 (legislation.gov.uk)

Welsh Government has published Non-statutory Guidance on the Regulations for Health Boards:
  • Non-statutory Guidance on the Regulations for Health Boards  English
  • Non-statutory Guidance on the Regulations for Health Boards Welsh

Changes to the NHS (2006) Act and the introduction of the NHS (Pharmaceutical Services) (Wales) Regulations 2020 changed the way in which pharmacy applications are granted (“market entry”) and, as of 1st October 2021, Heath Boards in Wales determine applications from community pharmacy contractors using their Pharmaceutical Needs Assessment (PNA).

These same 2020 Regulations also set out the new powers allowing LHBs to take action where there are concerns regarding the provision of pharmaceutical services by pharmacy contractors which may involve breaches of their Terms of Service.  It includes the ability for LHBs to impose sanctions such as remedial or breach notices, withhold payments and ultimately remove a pharmacy contractor from a pharmaceutical list.

The aim of the sanctions is to ensure consistent provision of pharmaceutical services by contractors in compliance with their terms of service however, the ultimate outcome may be removal from the pharmaceutical list and collectively the powers are known as “market exit”.

CPW has drafted Guidance for contractors on Remedial and Breach Notices: Remedial and Breach Notices - A Guide for Pharmacy Contractors